Salta alla navigazione principale
Salta alla ricerca
Salta al contenuto principale
Ordina per
Medicine and Dentistry
Kidney Graft
100%
Patient
98%
Donor
83%
Transplantation
67%
Kidney Transplantation
52%
Kidney
42%
Therapeutic Procedure
39%
Nephrectomy
39%
Everolimus
34%
Tacrolimus
27%
Neoplasm
26%
Complication
24%
Kidney Function
24%
Incidence
21%
Follow up
21%
Acute Graft Rejection
20%
Cyclosporine
18%
Immunosuppressive Treatment
18%
Case Report
17%
Combination Therapy
16%
Non Melanoma Skin Cancer
15%
Bariatric Surgery
15%
Renal Artery Aneurysm
15%
Kidney Perfusion
15%
Immunosuppressive Drug
15%
T Cell
14%
Graft Survival
13%
Evaluation Study
13%
Enalapril Maleate
12%
Systematic Review
12%
Mycophenolate Mofetil
12%
Quality of Life
11%
Organ Transplantation
11%
Self Concept
11%
Recurrent Disease
10%
Low Drug Dose
9%
Drive
9%
Kidney Allograft
9%
Corticosteroid
9%
Surgery
9%
Diseases
9%
Female
8%
Preoperative Evaluation
8%
Scoring System
8%
Consensus
8%
Chronic Kidney Disease
8%
Basiliximab
8%
Anxiety
7%
Perception
7%
Atorvastatin
7%
Pharmacology, Toxicology and Pharmaceutical Science
Everolimus
65%
Tacrolimus
53%
Clinical Trial
21%
Immunosuppressive Agent
16%
Mycophenolate Mofetil
16%
Ciclosporin
16%
Atorvastatin
15%
Antibiotic Prophylaxis
15%
Everolimus
15%
Acetylcysteine
14%
Acute Graft Rejection
14%
Antibiotic Agent
13%
Calcineurin Inhibitor
12%
Basiliximab
12%
Rat
11%
Surgical Infection
9%
Thymocyte Antibody
9%
Basiliximab
8%
Survival
8%
Incidence
8%
Clinical Study
7%
Controlled Clinical Trial
7%
Heart Left Ventricle Hypertrophy
7%
Randomized Clinical Trial
7%
Atorvastatin
7%
Ciclosporin
7%
Tacrolimus
7%
Steroids
6%
Reperfusion Injury
6%
Wound
5%
Corticosteroid
5%
Creatinine
5%
Immunology and Microbiology
Transplantation
53%
Kidney
41%
Basiliximab
18%
Tacrolimus
15%
Everolimus
14%
Electric Potential
12%
Dose
12%
Antiphospholipid Syndrome
10%
Acute Graft Rejection
9%
Immunosuppressive Drug
8%
Renal Transplantation
7%
Life
7%
Anti-Thymocyte Globulin
7%
Cytomegalovirus
7%
Kidney Transplantation
7%
Insulin Resistance
7%
Antibody Response
7%
T Cell
7%
Insulin Sensitivity
7%
Adipose Tissue
7%
Consensus
6%
Ciclosporin
6%
Organ
5%
Mycophenolic Acid
5%
Immunosuppression
5%
